Viewing StudyNCT00354523



Ignite Creation Date: 2024-05-05 @ 4:58 PM
Last Modification Date: 2024-10-26 @ 9:26 AM
Study NCT ID: NCT00354523
Status: TERMINATED
Last Update Posted: 2014-12-17
First Post: 2006-07-18

Brief Title: Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center

Conditions & Keywords Data

Conditions:
Name
Thyroid Cancer
Solid Tumor
Keywords:
Name View
Xeloda View
Solid Tumor View
Thyroid Cancer View
Medullary Thyroid Cancer View
MTC View
Advanced Metastatic Medullary Thyroid Carcinoma View
Capecitabine View
Dacarbazine View
Imatinib View
Gleevec View
Imatinib Mesylate View
DTIC-Dome View